Novel Structure Elucidation Strategy for Genetically Abnormal Fibrinogens with Incomplete Fibrinopeptide Release as Applied to Fibrinogen Schwarzach

Authors:
  • AHAgnes Henschen
    Agnes Henschen
  • MKMaria Kehl
    Maria Kehl
  • EDErwin Deutsch
    Erwin Deutsch

Abstract
A novel and simple strategy was developed for the structure elucidation of those genetically abnormal fibrinogens in which thrombin is unable to release fibrinopeptide A from the abnormal molecules. The method provides evidence for the Arg leads to Cys exchange at the C-terminus of the fibrinopeptide A sequence. The abnormal fibrinogen was mercaptolysed and then S-amino-ethylated. Upon thrombin digestion, the modified fibrinogen released new peptides, as shown by high-performance liquid chromatography. The amino-acid analysis proved that these peptides correspond to the expected fibrinopeptide A variants. It was therefore concluded that the analysed case of dysfibrinogenemia, designated Fibrinogen Schwarzach, contains an A alpha 16 Arg leads to Cys exchange in the heterozygous form.

This publication has 2 references indexed in Scilit: